Formation and metabolism of alkylated nucleosides: Possible role in carcinogenesis by nitroso compounds and alkylating agents

Research output: Contribution to journalArticle

307 Citations (Scopus)

Abstract

Alkylation of nucleic acids occurs both physiologically within living cells and after the administration of compounds that are either themselves direct chemical alkylating agents or are converted into alkylating agents by metabolic activation. Some of these compounds are highly potent carcinogens. Carcinogenicity of these agents is due to the alkylation of certain cellular components because no other degradation product nor is the compound itself oncogenic. This chapter deals with the formation and metabolism of alkylated purines in nucleic acids. It briefly discusses other alkylation reactions leading to the alkylphosphate triester production and alkylated pyrimidines. It also presents evidences favoring particular critical targets for the action of alkylating carcinogens. The attack on nucleic acids by carcinogenic alkylating agents is not entirely random and generally leads to the formation of alkylated nucleosides at many different sites distributed throughout the cellular nucleic acids. Carcinogenesis is not necessarily mediated through mutagenesis in somatic cells. However, it is observed that carcinogenic action could be mediated through a distinct action of the electrophilic reactant.

Original languageEnglish (US)
Pages (from-to)195-269
Number of pages75
JournalAdvances in Cancer Research
Volume25
Issue numberC
DOIs
StatePublished - Jan 1 1977

Fingerprint

Nitroso Compounds
Alkylating Agents
Nucleosides
Nucleic Acids
Carcinogenesis
Alkylation
Carcinogens
Pyrimidines
Purines
Mutagenesis

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

@article{f2054f57e8a343e9bf86bc6d39629d99,
title = "Formation and metabolism of alkylated nucleosides: Possible role in carcinogenesis by nitroso compounds and alkylating agents",
abstract = "Alkylation of nucleic acids occurs both physiologically within living cells and after the administration of compounds that are either themselves direct chemical alkylating agents or are converted into alkylating agents by metabolic activation. Some of these compounds are highly potent carcinogens. Carcinogenicity of these agents is due to the alkylation of certain cellular components because no other degradation product nor is the compound itself oncogenic. This chapter deals with the formation and metabolism of alkylated purines in nucleic acids. It briefly discusses other alkylation reactions leading to the alkylphosphate triester production and alkylated pyrimidines. It also presents evidences favoring particular critical targets for the action of alkylating carcinogens. The attack on nucleic acids by carcinogenic alkylating agents is not entirely random and generally leads to the formation of alkylated nucleosides at many different sites distributed throughout the cellular nucleic acids. Carcinogenesis is not necessarily mediated through mutagenesis in somatic cells. However, it is observed that carcinogenic action could be mediated through a distinct action of the electrophilic reactant.",
author = "Anthony Pegg",
year = "1977",
month = "1",
day = "1",
doi = "10.1016/S0065-230X(08)60635-1",
language = "English (US)",
volume = "25",
pages = "195--269",
journal = "Advances in Cancer Research",
issn = "0065-230X",
publisher = "Academic Press Inc.",
number = "C",

}

TY - JOUR

T1 - Formation and metabolism of alkylated nucleosides

T2 - Possible role in carcinogenesis by nitroso compounds and alkylating agents

AU - Pegg, Anthony

PY - 1977/1/1

Y1 - 1977/1/1

N2 - Alkylation of nucleic acids occurs both physiologically within living cells and after the administration of compounds that are either themselves direct chemical alkylating agents or are converted into alkylating agents by metabolic activation. Some of these compounds are highly potent carcinogens. Carcinogenicity of these agents is due to the alkylation of certain cellular components because no other degradation product nor is the compound itself oncogenic. This chapter deals with the formation and metabolism of alkylated purines in nucleic acids. It briefly discusses other alkylation reactions leading to the alkylphosphate triester production and alkylated pyrimidines. It also presents evidences favoring particular critical targets for the action of alkylating carcinogens. The attack on nucleic acids by carcinogenic alkylating agents is not entirely random and generally leads to the formation of alkylated nucleosides at many different sites distributed throughout the cellular nucleic acids. Carcinogenesis is not necessarily mediated through mutagenesis in somatic cells. However, it is observed that carcinogenic action could be mediated through a distinct action of the electrophilic reactant.

AB - Alkylation of nucleic acids occurs both physiologically within living cells and after the administration of compounds that are either themselves direct chemical alkylating agents or are converted into alkylating agents by metabolic activation. Some of these compounds are highly potent carcinogens. Carcinogenicity of these agents is due to the alkylation of certain cellular components because no other degradation product nor is the compound itself oncogenic. This chapter deals with the formation and metabolism of alkylated purines in nucleic acids. It briefly discusses other alkylation reactions leading to the alkylphosphate triester production and alkylated pyrimidines. It also presents evidences favoring particular critical targets for the action of alkylating carcinogens. The attack on nucleic acids by carcinogenic alkylating agents is not entirely random and generally leads to the formation of alkylated nucleosides at many different sites distributed throughout the cellular nucleic acids. Carcinogenesis is not necessarily mediated through mutagenesis in somatic cells. However, it is observed that carcinogenic action could be mediated through a distinct action of the electrophilic reactant.

UR - http://www.scopus.com/inward/record.url?scp=0017441016&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017441016&partnerID=8YFLogxK

U2 - 10.1016/S0065-230X(08)60635-1

DO - 10.1016/S0065-230X(08)60635-1

M3 - Article

C2 - 326002

AN - SCOPUS:0017441016

VL - 25

SP - 195

EP - 269

JO - Advances in Cancer Research

JF - Advances in Cancer Research

SN - 0065-230X

IS - C

ER -